Sutro Biopharma, Inc. ( STRO) - Stock Earnings
STRO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -56.9 million USD | 9.7 million USD |
| 2025Q4 | -46.8 million USD | 11.6 million USD |
| 2026Q1 | -38.5 million USD | 14.5 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
STRO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -106.8 million USD | 153.7 million USD |
| 2024 | -227.5 million USD | 62.0 million USD |
| 2025 | -191.1 million USD | 102.5 million USD |
| 2026 Est. | — | — |
STRO
Price: $28.17
52 week price:
Earnings Per Share: -16.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 223541
Market Capitalization: 249.6 million